Home Cart 0 Sign in  

[ CAS No. 328-74-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 328-74-5
Chemical Structure| 328-74-5
Structure of 328-74-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 328-74-5 ]

Related Doc. of [ 328-74-5 ]

Alternatived Products of [ 328-74-5 ]
Product Citations

Product Citations

Tanner J. Schumacher ; Ananth V. Iyer ; Jon Rumbley , et al. DOI:

Abstract: Cancer cells alter their metabolic phenotypes with nutritional change. Single agent approaches targeting mitochondrial metabolism in cancer have failed due to either dose limiting off target toxicities, or lack of efficacy in vivo. To mitigate these clinical challenges, we investigated the potential utility of repurposing FDA approved mitochondrial targeting anthelmintic agents, niclosamide and pyrvinium pamoate, to be combined with GLUT1 inhibitor BAY-876 to enhance the inhibitory capacity of the major metabolic phenotypes exhibited by tumors. To test this, we used breast cancer cell lines MDA-MB-231 and 4T1 which exhibit differing basal metabolic rates of glycolysis and mitochondrial respiration, respectively. Here, we found that specific responses to mitochondrial and glycolysis targeting agents elicit responses that correlate with tested cell lines basal metabolic rates and fuel preference, highlighting the potential to cater metabolism targeting treatment regimens based on specific tumor nutrient handling. Inhibition of GLUT1 with BAY-876 potently inhibited glycolysis in both MDA-MB-231 and 4T1 cells, and niclosamide and pyrvinium pamoate perturbed mitochondrial respiration that resulted in potent compensatory glycolysis in the cell lines tested. In this regard, combination of BAY-876 with both mitochondrial targeting agents resulted in inhibition of compensatory glycolysis and subsequent metabolic crisis. These studies warrant further investigation into targeting tumor metabolism as a combination treatment regimen that can be tailored by basal and compensatory metabolic phenotypes.

Purchased from AmBeed: ;

Product Details of [ 328-74-5 ]

CAS No. :328-74-5 MDL No. :MFCD00000394
Formula : C8H5F6N Boiling Point : -
Linear Structure Formula :C6H3(CF3)2(NH2) InChI Key :CDIDGWDGQGVCIB-UHFFFAOYSA-N
M.W : 229.12 Pubchem ID :9480
Synonyms :

Calculated chemistry of [ 328-74-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.85
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 3.57
Log Po/w (WLOGP) : 5.62
Log Po/w (MLOGP) : 3.59
Log Po/w (SILICOS-IT) : 3.2
Consensus Log Po/w : 3.53

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.67
Solubility : 0.0486 mg/ml ; 0.000212 mol/l
Class : Soluble
Log S (Ali) : -3.8
Solubility : 0.0361 mg/ml ; 0.000158 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.82
Solubility : 0.0348 mg/ml ; 0.000152 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.38

Safety of [ 328-74-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 328-74-5 ]

Fluorinated Building Blocks

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 1.00

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.98

Chemical Structure| 455-14-1

[ 455-14-1 ]

4-(Trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.95

Chemical Structure| 243128-44-1

[ 243128-44-1 ]

2-Methyl-3,5-bis(trifluoromethyl)aniline

Similarity: 0.93

Aryls

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 1.00

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.98

Chemical Structure| 455-14-1

[ 455-14-1 ]

4-(Trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.95

Chemical Structure| 243128-44-1

[ 243128-44-1 ]

2-Methyl-3,5-bis(trifluoromethyl)aniline

Similarity: 0.93

Amines

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 1.00

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.98

Chemical Structure| 455-14-1

[ 455-14-1 ]

4-(Trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.95

Chemical Structure| 243128-44-1

[ 243128-44-1 ]

2-Methyl-3,5-bis(trifluoromethyl)aniline

Similarity: 0.93

Trifluoromethyls

Chemical Structure| 96100-12-8

[ 96100-12-8 ]

3-Amino-5-methylbenzotrifluoride

Similarity: 1.00

Chemical Structure| 368-53-6

[ 368-53-6 ]

5-(Trifluoromethyl)benzene-1,3-diamine

Similarity: 0.98

Chemical Structure| 455-14-1

[ 455-14-1 ]

4-(Trifluoromethyl)aniline

Similarity: 0.97

Chemical Structure| 368-71-8

[ 368-71-8 ]

4-(Trifluoromethyl)benzene-1,2-diamine

Similarity: 0.95

Chemical Structure| 243128-44-1

[ 243128-44-1 ]

2-Methyl-3,5-bis(trifluoromethyl)aniline

Similarity: 0.93

; ;